CovidResearchTrials by Shray Alag


CovidResearchTrials Covid 19 Research using Clinical Trials (Home Page)


Self-administered questionnairesWiki

Developed by Shray Alag
Clinical Trial MeSH HPO Drug Gene SNP Protein Mutation


Correlated Drug Terms (0)


Name (Synonyms) Correlation

Correlated MeSH Terms (1)


Name (Synonyms) Correlation
D019052 Depression, Postpartum NIH 0.45

Correlated HPO Terms (0)


Name (Synonyms) Correlation

There is one clinical trial.

Clinical Trials


1 Birth Experience During COVID-19 Confinement (Confinement and Fostering Intrapartum Care)

Different studies have demonstrated that the absence of companionship during labor and childbirth may be responsible for a negative birth experience, an increased risk of postnatal depression and/or post traumatic stress disorders. These situation may also have a negative impact on mother-child interaction, on marital and family relationship and on the rate of maternal suicide in postpartum. However, these previous results cannot be extrapolated in the current context where the absence of the companionship is imposed by the confinement framework. The objective of the CONFINE study is to assess, for the first time, the birth experience of women in the context of limited social support in the immediate post-partum period due to confinement, as well as the associated over-risk of mental disorders, compared to a post-partum without social restriction.

NCT04348929 Postpartum Depression Other: Self-administered questionnaires
MeSH:Depression, Postpartum

Primary Outcomes

Measure: "Labor Agentry Scale questionnaire" score in immediate post-partum (duration of hospital stay)

Time: through study completion, an average of 16 months

Secondary Outcomes

Measure: "Labor Agentry Scale questionnaire" score at two months after birth

Time: through study completion, an average of 16 months

Description: To detect suspicion of Post-Partum Depression

Measure: Edinburg Postnatale Depression Scale questionnaire" score at two months after birth

Time: through study completion, an average of 16 months

Description: To detect suspicion of Post traumatic stress syndrome

Measure: "Impact of Event Scale - Revised questionnaire" score at two months after birth

Time: through study completion, an average of 16 months

Measure: Breastfeeding statement at two months after birth

Time: through study completion, an average of 16 months

Measure: "SF-12 Quality of life questionnaire" score at two months after birth

Time: through study completion, an average of 16 months

Measure: "SF-12 Quality of life questionnaire" score in immediate post-partum

Time: through study completion, an average of 16 months


No related HPO nodes (Using clinical trials)